{"type":"rich","version":"1.0","title":"Novo Undercuts Lilly’s Obesity Drug Price for Cash-Pay in US ","author_name":"Bloomberg Intelligence","author_url":"https://bloomberg.com/podcasts/taking_stock","provider_name":"Omny Studio","provider_url":"https://omny.fm","html":"<iframe src=\"https://omny.fm/shows/the-tape/novo-undercuts-lilly-s-obesity-drug-price-for-cash-pay-in-us/embed\" width=\"100%\" height=\"180\" allow=\"autoplay; clipboard-write; fullscreen\" allowfullscreen frameborder=\"0\" title=\"Novo Undercuts Lilly’s Obesity Drug Price for Cash-Pay in US \"></iframe>","width":600,"height":180}